Cleared Traditional

K092608 - SYNTHETIC MINERAL-COLLAGEN BONE GRAFT MATRIX

K092608 is an FDA 510(k) clearance for SYNTHETIC MINERAL-COLLAGEN BONE GRAFT M..., manufactured by Collagen Matrix, Inc.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 276-day FDA review.

K092608 · Collagen Matrix, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
276d
Days
Class 2
Risk

K092608 is an FDA 510(k) clearance for the SYNTHETIC MINERAL-COLLAGEN BONE GRAFT MATRIX. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Collagen Matrix, Inc. (Franklin Lakes, US). The FDA issued a Cleared decision on May 28, 2010 after a review of 276 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Collagen Matrix, Inc. devices

FDA 510(k) Submission Details - K092608

510(k) Number K092608 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 25, 2009
Decision Date May 28, 2010
Days to Decision 276 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
154d slower than avg
Panel avg: 122d · This submission: 276d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 479
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K092608.
CALLOS BONE VOID FILLER, SKAFFOLD NEXT GENERATION BONE VOID FILLER, OSTEO VATION
K100986 · Skeletal Kinetics, LLC · Jul 2010
GAMMA-BSM, BETA-BSM, EQUIVABONE, CARIGEN
K101557 · Etex Corp. · Jul 2010
B-GENIN AND R-GENIN
K091912 · Berkeley Advanced Biomaterials, Inc. · Jun 2010
GRAFTY QUICKSET
K093343 · Graftys · Apr 2010
NANOSS BONE VOID FILLER
K100361 · Pioneer Surgical Technology · Apr 2010
BI-OSTETIC FOAM AND PUTTY, GENEROS FOAM AND PUTTY
K092046 · Berkeley Advanced Biomaterials, Inc. · Mar 2010